Evidence map›Paper›PMID 40721823›Full record

ArticleTropical medicine and health2025

Intra-familial transmission of Hepatitis B virus in a peri-urban community from the Democratic Republic of the Congo.

Florence Cindibu Kalonji, Yu Nakagama, Evariste Tshibangu-Kabamba, Nadine Kayiba Kalenda, Shun Nakagama, Sachie Nakagama, Pathy Kamanga Nkolongo, Nestor Kalala-Tshituka, Alphonse Lufuluabu Mpemba, Faustin Ndjibu Mpoji and 7 more

Abstract read
In one paragraph

Article in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Florence Cindibu KalonjiDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Yu NakagamaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Evariste Tshibangu-KabambaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Nadine Kayiba KalendaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Shun NakagamaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Sachie NakagamaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Pathy Kamanga NkolongoDepartment of Internal Medicine, Faculty of Medicine-Pharmacy and Public Health, University of Mbujimayi, Mbujimayi, Democratic Republic of Congo.
Nestor Kalala-TshitukaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Alphonse Lufuluabu MpembaDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Faustin Ndjibu MpojiDepartment of Public Health, Faculty of Medicine-Pharmacy and Public Health, University of Mbujimayi, Mbujimayi, Democratic Republic of Congo.
André Kabongu KalalaDepartment of Public Health, Faculty of Medicine-Pharmacy and Public Health, University of Mbujimayi, Mbujimayi, Democratic Republic of Congo.
Benjamin Muamba MpoyiSecondary Hospital of Katanda, Mbujimayi, Kasaï-Oriental, Democratic Republic of Congo.
Dieudonné Mumba NgoyiDepartment of Parasitology, National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo.
Natsuko KakuDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan.
Yusuke ShimakawaInstitut Pasteur, Université Paris Cité, Unité d'Épidémiologie des Maladies Émergentes, Paris, France.
Ghislain Tumba DisashiDepartment of Internal Medicine, Faculty of Medicine-Pharmacy and Public Health, University of Mbujimayi, Mbujimayi, Democratic Republic of Congo.
Yasutoshi KidoDepartment of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-Cho, Abeno-Ku, Osaka-Shi, Osaka, 545-8585, Japan. kidoyasu@omu.ac.jp.

Funding

Japan Agency for Medical Research and Development JP25wm0125003Japan Agency for Medical Research and Development (AMED) JP19fm0208020Japan Society for the Promotion of Science (JSPS) KAKENHI 22KK0279Japan Society for the Promotion of Science (JSPS) KAKENHI JP18KK0454JSPS Core-to-Core Program JPJSCCB20240010
6 · The paper itself

Abstract

backgroundDespite global elimination targets set for 2030, Hepatitis B virus (HBV) infection remains a major public health challenge in low-income countries, including the Democratic Republic of Congo (DRC). Limited evidence on the regional transmission pathways precludes progress towards HBV elimination. This study aimed to assess the prevalence, molecular characteristics, and transmission dynamics of HBV in the Lukelenge health district, a peri-urban area in central DRC.

methodsWe employed a two-tiered recruitment strategy: community member volunteers were enrolled during the first phase, and upon notification of HBV positivity in an index case, family contacts were subsequently recruited in the second phase. Participants were screened for hepatitis B surface antigen (HBsAg), followed by PCR amplification of HBV DNA and sequencing. Genotyping and phylogenetic analysis of preS/S sequences were performed to explore regional HBV diversity and transmission patterns.

resultsA total of 751 participants from 677 households were included. The overall HBsAg prevalence was 3.8% [95% CI 2.6-5.7], with the highest rate (10.1% [95% CI 4.9-18.2]) found in children aged 5 years and younger. All 42 HBV isolates belonged to genotype E, with 97.6% sharing the ayw4 serotype. Mutations with relevancy to immune escape were detected in 9.5% of strains, while those possibly linked to antiviral resistance were found in 4.7%. Maximum likelihood phylogenetic analysis showed intra-familial clustering of preS/S sequences, suggesting that parent-to-child transmission was the most frequent mode of HBV spread in the study population.

conclusionsHBV in Lukelenge shows intermediate endemicity, especially affecting young children. Intra-familial transmission is revealed to be predominant, likely involving both vertical and horizontal pathways. Family-targeted interventions, including maternal screening and universal birth-dose vaccination, should be prioritized to eliminate HBV in this region.

Indexed as

CommunityDemocratic Republic of CongoHepatitis B virusIntra-familialPeri-urbanTransmission

Identifiers

PMID40721823
PMCPMC12302796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.